• Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives Average Recommendation of "Moderate Buy" from Brokerages

    Source: Buzz FX / 12 Jan 2025 03:41:15   America/Chicago


    Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives Average Recommendation of "Moderate Buy" from Brokerages Written by MarketBeat January 12, 2025 Share Link copied to clipboard. Shares of Regulus Therapeutics Inc.
    Read more...
Share on,